Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms
- Resource Type
- Source
- Leukemia & Lymphoma. :1-3
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 1029-2403
1042-8194